• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Metagenomi, Inc. - Common Stock (NQ: MGX )

    2.110 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.110
    Bid (Size) 1.870 (5)
    Ask (Size) 2.950 (20)
    Prev. Close 2.110
    Today's Range 2.110 - 2.110
    52wk Range 1.850 - 12.74
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
    From Metagenomi, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -79.53%
    -79.53%
    1 Month
    +5.50%
    +5.50%
    3 Month
    -44.18%
    -44.18%
    6 Month
    -67.34%
    -67.34%
    1 Year
    -79.53%
    -79.53%

    More News

    Read More
    METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
    From Berger Montague
    Via GlobeNewswire
    METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Metagenomi to Contact Us to Have Their Losses Evaluated Today
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    MGX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
    From Metagenomi, Inc.
    Via GlobeNewswire
    Faruqi & Faruqi Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024 - MGX
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Agenus, and New Fortress and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    SHAREHOLDER ALERT: Berger Montague Reminds Metagenomi (NASDAQ: MGX) Investors of Class Action Lawsuit Deadline
    From Berger Montague
    Via GlobeNewswire
    MGX INVESTOR ALERT: Kirby McInerney LLP Reminds Metagenomi Inc. Investors of Deadline in Class Action Lawsuit
    From Kirby McInerney LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    MGX Stock News: Robbins LLP Reminds Investors with Large Losses of the Class Action Lawsuit Against Metagenomi Inc.
    From Robbins LLP
    Via GlobeNewswire
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    INVESTOR REMINDER: Berger Montague Notifies Metagenomi (NASDAQ: MGX) Investors of a Class Action Lawsuit and Deadline
    From Berger Montague
    Via GlobeNewswire
    Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
    From Metagenomi, Inc.
    Via GlobeNewswire
    METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Kirby McInerney LLP Notifies Metagenomi Inc. (MGX) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    From Kirby McInerney LLP
    Via Business Wire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    MGX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Metagenomi, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.